Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Achillion Pharma PNH treatment Danicopan gets European Medicines Agency PRIME DesignationAchillion Pharma PNH treatment Danicopan gets European Medicines Agency PRIME Designation
    Chinese strategy: Dr Reddys outsources part manufacturing to local partiesChinese strategy: Dr Reddy's outsources part manufacturing to local parties
    Cabinet nod to extension of pharmaceuticals purchase policy for pharma PSUsCabinet nod to extension of pharmaceuticals purchase policy for pharma PSUs
    FIRST: Roche wins DCGI nod for Atezolizumab to treat small-cell lung cancerFIRST: Roche wins DCGI nod for Atezolizumab to treat small-cell lung cancer
    Laurus Labs gets 3 USFDA observations for Visakhapatnam facilityLaurus Labs gets 3 USFDA observations for Visakhapatnam facility
    Zydus Cadila Desonide Cream, Isosorbide Dinitrate tablets get USFDA approvalZydus Cadila Desonide Cream, Isosorbide Dinitrate tablets get USFDA approval
    Alnylams rare genetic disorder drug gets early U.S. approvalAlnylam's rare genetic disorder drug gets early U.S. approval
    Charity to pay $4 million to resolve U.S. pharma kickback probeCharity to pay $4 million to resolve U.S. pharma kickback probe
    China plans to add more drugs to price-slashing bulk-buy programChina plans to add more drugs to price-slashing bulk-buy program
    Fake doctors, misleading claims drive OxyContin China salesFake doctors, misleading claims drive OxyContin China sales
    With questions about safety of Merils Made in India BVS stent, NPPA defers its appeal for price exemptionWith questions about safety of Meril's Made in India BVS stent, NPPA defers its appeal for price...
    China to launch inspection on production, sale, use of illegal African swine fever vaccinesChina to launch inspection on production, sale, use of illegal African swine fever vaccines
    PrevNext

    Popular Stories

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Supreme Court to hear PIL seeking direction to govt for banning unregulated medical devices

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Top Pharmacy Courses That Rule the Industry

    Top Pharmacy Courses That Rule the Industry

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok